THLD
Knobias Clip Report (10-12-2007)
Monday, October 15th, 2007Rating 3.00 out of 5
[?]Sumbmited From Knobias ClipReport
THLD: Shares Decline After Ph II Trial of Glufosfamide Fails to Meet Endpoint
Shares of Threshold Pharmaceuticals, Inc. (THLD) declined in Friday’s session after anouncing after the bell yesterday that it would stop enrollment in a Phase 2 clinical trial of its lead product candidate, glufosfamide, in patients with […]
